SCHEMBL103194

SCHEMBL103194

O=C(OC1CCOc2ccccc21)ON1CCN(CCC(=O)c2ccc3[nH]c(=O)oc3c2)CC1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ENPP2 Q13822 7/20 0.55
GRIN2D O15399 1/20 0.50
GRIN3B O60391 1/20 0.50
GRIN1 Q05586 1/20 0.50
GRIN2A Q12879 1/20 0.50
GRIN2B Q13224 1/20 0.50
GRIN2C Q14957 1/20 0.50
GRIN3A Q8TCU5 1/20 0.50
KCNH2 Q12809 1/20 0.48
ALDH1A1 P00352 5/20 0.39
KDM4E B2RXH2 2/20 0.39
MAPT P10636 4/20 0.38
HTT P42858 3/20 0.38
LMNA P02545 2/20 0.38
TAAR1 Q96RJ0 2/20 0.38
HIF1A Q16665 1/20 0.38
GAA P10253 1/20 0.38
CREBBP Q92793 1/20 0.37
TP53 P04637 1/20 0.37
ALDH3A1 P30838 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL171624 0.90 ENPP2 (0.64) ENPP2GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL105154 0.87 ENPP2 (0.56) ENPP2GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL106566 0.83 ENPP2 (0.59) ENPP2GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL105676 0.79 ENPP2 (0.62) ENPP2GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL105919 0.79 ENPP2 (0.77) ENPP2GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL15135277 0.78 ENPP2 (0.66) ENPP2GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL3055788 0.78 ENPP2 (0.51) ENPP2GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL104926 0.77 ENPP2 (0.67) ENPP2GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL104293 0.77 ENPP2 (0.61) ENPP2GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL171681 0.77 ENPP2 (0.66) ENPP2GRIN2DGRIN3BGRIN1GRIN2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2426106-B1 Piperidine and Piperazine derivatives for the treatment of tumours MERCK PATENT GMBH (DE) 2013-07-31 EP claimed
EP-2426106-A1 Piperidine and Piperazine derivatives for the treatment of tumours Merck Patent GmbH (DE) 2012-03-07 EP claimed
EP-2426106-B1 Piperidine and Piperazine derivatives for the treatment of tumours MERCK PATENT GMBH (DE) 2013-07-31 EP disclosed
EP-2426106-A1 Piperidine and Piperazine derivatives for the treatment of tumours Merck Patent GmbH (DE) 2012-03-07 EP disclosed